Omixon at BSHI 2013 in Manchester

02/09/2013

We are going to exhibit at the upcoming BSHI 2013 meeting, 4-5 September 2013, Manchester, UK. Manchester has historically been a scientific centre in the UK; home to scientists such as Dalton, Rutherford and more recently Alan Turing and Professor Brian Cox. We are happy to announce that our recently appointed CEO, Tim...

Congratulations to Omixon’s new CEO!

13/08/2013

We congratulate Tim Hague for taking over the CEO responsibilities for Omixon. Attila Berces will continue as Chairman of the Board and will focus on the strategic relationships of the company. “Tim has demonstrated outstanding leadership qualities and it is a natural step for him to advance to the...

Omixon’s upcoming HLA typing webinar

20/06/2013

Broadcast date: 3rd July 2013, Wednesday Time: 12.00-1.00 PM EDT/ 18.00-19.00 CET Come and join our CEO, Attila Berces online in a presentation and demo of how Omixon Target HLA typing will bring you value during the analysis of NGS data. Our guest speaker is Dr. Dimitri Monos, University of Pennsylvania and The Children”s...

Omixon and Knome partner to offer advanced HLA typing for whole genome!

05/06/2013

We have great news today as Omixon Biocomputing and Knome has become partners to offer advanced HLA typing for whole genome and exome level data. We believe that this partnership will help us “discover safer and more efficient therapies by identifying genomic biomarkers for drug response and adverse response,”...

Omixon is attending TCGC in San Francisco. Meet us there!

20/05/2013

The Clinical Genome Conference (TCGC) 2013 brings together many constituencies for frank and vital discussion of the applications, questions and solutions surrounding clinical genome analysis, including scientists, physicians, diagnosticians, genetic counselors, bioinformaticists, ethicists, regulators, insurers, lawyers, and administrators. Omixon is exhibiting at TCGC in San Francisco, from 25th to...